Table 1.

Clinical characteristic.

Clinical characteristic	High-risk plaque group (n=57)	Low-risk plaque group (n=26)	P
Male sex n (%)	37 (64.9%)	12 (46.2%)	0.107
Age years	62 ± 10	62 ± 10	0.940
Hypertension n (%)	34 (59.6%)	16 (61.5%)	0.870
Diabetes mellitus n (%)	18 (31.6%)	1 (3.8%)	0.005
Current smoking n (%)	32 (56.1%)	5 (19.2%)	0.002
White blood cell count 10*9/L	6.02 (5.16,7.05)	5.83 (4.85,6.28)	0.148
Red blood cell count 10*12/L	4.29 ± 0.56	4.46 ± 0.42	0.135
Hemoglobin g/L	129 ± 18	134 ± 14	0.204
Platelet count 10*9/L	202 ± 65	216 ± 55	0.340
NLR	2.21 (1.58,3.32)	1.80 (1.52,2.36)	0.094
Total cholesterol mmol/L	3.69 (3.26,4.45)	3.55 (2.85,4.01)	0.092
Triglyceride mmol/L	1.35 (1.06,2.04)	1.46 (1.13,1.64)	0.772
HDL-C mmol/L	0.98 (0.83,1.18)	0.91 (0.87,1.18)	0.922
LDL-C mmol/L	2.19 (1.69,2.98)	1.97 (1.55,2.62)	0.182
Lipoprotein (a)	212 (138,363)	98 (52,223)	0.003
Apolipoprotein A1 g/L	1.00 (0.88,1.15)	0.97 (0.93,1.10)	0.772
Apolipoprotein B g/L	0.76 (0.58,0.92)	0.64 (0.47,0.83)	0.053
Fasting blood glucose mmol/L	5.38 (4.61,6.04)	4.99 (4.33,5.91)	0.314
Uric acid μmol/L	279 (220,323)	312 (267,369)	0.030
Creatinine μmol/L	67 (59,74)	65 (55,74)	0.348
NT-proBNP pg/ml	77 (33,150)	63 (38,677)	0.527
Creatine kinase U/L	76 (46,109)	61 (47,95)	0.453